Recent HAE Stock Price | HAE Stock Predictions | |
$83.46 | +26.77% |
$105.80 |
Recent HAE Analyst Ratings Breakdown, Making HAE Stock Predictions | ||||
---|---|---|---|---|
Current | 1 Mo. Ago | 2 Mo. Ago | 3 Mo. Ago | |
Strong buy ratings: | 3 | 3 | 3 | 3 |
Buy ratings: | 1 | 1 | 1 | 1 |
Hold ratings: | 2 | 2 | 2 | 2 |
Sell ratings: | 0 | 0 | 0 | 0 |
Strong sell ratings: | 0 | 0 | 0 | 0 |
Average rating: | 1.83 | 1.83 | 1.83 | 1.83 |
For the HAE stock predictions from the analysts covering Haemonetics Corp., we have collected all of the individual HAE stock predictions for stock price one year from now (i.e. each analyst's "forward price target") and at the top of this page we have presented the average prediction across the 5 different analysts covering HAE (as reported in
data provided by Zacks Investment Research via Quandl.com).
But since HAE stock predictions may vary widely, another useful metric to consider is the median HAE stock prediction, which represents the price at which half of the analysts
made HAE stock predictions that were higher and half made HAE stock predictions that were lower. This makes for a different take on the HAE stock predictions out there, as compared to average or mean.
And that median across all the individual HAE stock predictions was: $105.0 as of 2024-04-19.
The very highest of the HAE stock predictions for one year price target was $115.0, while the very lowest of the HAE stock predictions in the analyst group was
$94.0 (with a standard deviation of $9.257). Get the latest Zacks research report on HAE — FREE
Find out: HAE next earnings date »
Dividend Growth Stocks: 25 Aristocrats
10 Dividend Bargains You Can Buy Cheaper Than Insiders Did
Other stock predictions:
NOVA Stock Predictions
CLI Stock Predictions
MET Stock Predictions
WLDN Stock Predictions
OI Stock Predictions
MMSI Stock Predictions
SLM Stock Predictions
TECK Stock Predictions
FOXF Stock Predictions
|
|
Buy (3.17 out of 4) 100th percentile
(ranked higher than approx. 100% of all stocks covered)
Based on data provided by Zacks Investment Research via Quandl.com |